The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Cellular and Molecular Life Sciences"
DOI: 10.1007/s00018-019-03327-7
Abstract: Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease of the central nervous system with unknown etiology. Currently approved disease-modifying treatment modalities are immunomodulatory or immunosuppressive. While the applied drugs reduce the frequency and… read more here.
Keywords: sclerosis; remyelination; role galectins; emerging role ... See more keywords